Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed COO
Appointed director
Letter to company
Director departure
Urigen Pharmaceuticals, Inc. (URGP)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
12/18/2007
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
06/12/2007
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
04/26/2006
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
07/30/2004
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
05/18/2004
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
02/27/2004
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
02/12/2004
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
02/23/1999
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
02/18/1999
424B3
Form 424B3 -- Prospectus [Rule 424(b)(3)]
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy